<!-- SC_OFF --><div class="md"><p>Basically the title. Due to the nonsensical situation of NeurIPS being fully sold out before the results were even released, I couldn't get
<!-- SC_OFF --><div class="md"><p>My paper got rejected from an imaging venue (A*) because it lacked clinical validation and was more "NLP suited". I'm very disappointed
<!-- SC_OFF --><div class="md"><p>Hi everyone 👋 My paper was recently accepted to ICONIP 2026, but I’m the sole author and most likely won’t be able to attend the conference in
<!-- SC_OFF --><div class="md"><p>Got my first authored paper accepted at NeurIPS this year and trying to decide where to go. Would I miss out a lot by skipping Sydney and just
<!-- SC_OFF --><div class="md"><p>As a fellow ML researcher, I feel disheartened and discouraged after seeing the experiences of people who submitted their work to ICML 2026.
<!-- SC_OFF --><div class="md"><p>To all those in the US: Are you planning to go Sydney or Atlanta this year for NeurIPS? </p> </div><!-- SC_ON -->   submitted by   <a
<!-- SC_OFF --><div class="md"><p>I got accepted into EEML and I’m a little confused about travel and stay.</p> <p>Has anyone else from India been accepted? Let’s connect!</p>
<!-- SC_OFF --><div class="md"><p>I’m thinking about attending an AI conference in San Francisco this September, but the 2-day pass is around <strong>$1,200</strong>. For those
NewsHive monitors these sources continuously. All signal titles above link to the original reporting.
Intelligence by NewsHive. Need help navigating what this means for your business? Contact GeekyBee →